UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SAT0300 Treatment experience and satisfaction in ankylosing spondylitis patients treated with secukinumab: results from a us web-based survey

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1014

2018

Volltextzugriff (PDF)

FDA PATIENT-REPORTED OUTCOME LABELING OF NOVEL THERAPIES (2011-2015)

Value in health, 2016-05, Vol.19 (3), p.A285-A286

2016

Volltextzugriff (PDF)

United States decision maker perceptions of data from observational studies and other Health Economics and outcomes research

Value in health, 2015-05, Vol.18 (3), p.A75-A75

2015

Volltextzugriff (PDF)

PNS226 A CONSOLIDATED FRAMEWORK FOR COLLABORATION IN RWE GENERATION FOR A MEDICAL PRODUCT

Value in health, 2019-05, Vol.22, p.S324-S324

2019

Volltextzugriff (PDF)

Evidence-Based Medicine, Appropriate-Use Criteria, and Sports Medicine: How Best to Develop Meaningful Treatment Guidelines

Arthroscopy, 2013-07, Vol.29 (7), p.1224-1229

2013

Volltextzugriff (PDF)

PCR74 Trends in the Inclusion of Patient Reported Outcomes in Oncology Clinical Trials: Analysis of ClinicalTrials.gov (2013-2022)

Value in health, 2023-06, Vol.26 (6), p.S325-S325

2023

Volltextzugriff (PDF)

PRM111 Pediatric Patient-Reported Outcomes Assessment: A Case Study in Epidermolysis Bullosa

Value in health, 2012-11, Vol.15 (7), p.A480-A481

2012

Volltextzugriff (PDF)

Payer Needs In Emerging Markets: How Should These Needs Be Included In Dermatology Drug Development Plans?

Value in health, 2014-05, Vol.17 (3), p.A290-A290

2014

Volltextzugriff (PDF)

“Safe And Effective” Versus “Reasonable And Necessary”: Is The Deck Stacked Against Devices?

Value in health, 2013-05, Vol.16 (3), p.A246-A246

2013

Volltextzugriff (PDF)

Psychometric Evaluation Of The Patient's Knee Implant Performance (PKIP) Questionnaire For The Assessment Of Primary Total Knee Arthroplasty

Value in health, 2014-11, Vol.17 (7), p.A568-A568

2014

Volltextzugriff (PDF)

PHP182 Concordance of PRO Labeling Claims Between the FDA and EMA

Value in health, 2012-11, Vol.15 (7), p.A321-A321

2012

Volltextzugriff (PDF)

Psychometric Evaluation Of The Psoriasis Symptom Diary Using Phase 3 Trial Data

Value in health, 2014-05, Vol.17 (3), p.A288-A288

2014

Volltextzugriff (PDF)

MT61 Differences and Similarities of Health Economic Evaluation for Medical Technologies By HTA Bodies

Value in health, 2023-12, Vol.26 (12), p.S438

2023

Volltextzugriff (PDF)

MT25 What Evidence Should Medical Technology Companies Expect HTA Bodies to Review?

Value in health, 2023-12, Vol.26 (12), p.S431

2023

Volltextzugriff (PDF)

MT44 Submission Process and Requirements of Nordic Health Technology Assessment Organisations for Medical Technologies: Results of an Online Survey

Value in health, 2023-12, Vol.26 (12), p.S435

2023

Volltextzugriff (PDF)

MT13 Digging into the Medical Technology HTA Process in Tunisia

Value in health, 2023-12, Vol.26 (12), p.S429

2023

Volltextzugriff (PDF)

MT43 Does Real-World Evidence Play a Role in Decision-Making by HTA Bodies for Medical Technologies?

Value in health, 2023-12, Vol.26 (12), p.S434-S435

2023

Volltextzugriff (PDF)

MT29 Understanding How Health Technology Assessment Bodies Select Medical Technology for Review: Results of an Online Survey

Value in health, 2023-12, Vol.26 (12), p.S432

2023

Volltextzugriff (PDF)

PIH49 Patient Reported Outcomes as Primary Endpoints in Confirmatory Clinical Trials

Value in health, 2012-06, Vol.15 (4), p.A200-A200

2012

Volltextzugriff (PDF)

PIH53 Assessment of PRO Labels Claims Granted by the FDA as Compared to the EMA

Value in health, 2012-06, Vol.15 (4), p.A201-A201

2012

Volltextzugriff (PDF)

Surgical Innovation: Do We Need A More Balanced Framework For Evidence?

Value in health, 2013-05, Vol.16 (3), p.A247-A247

2013

Volltextzugriff (PDF)

MT16 What Is the Medical Technology HTA Process in Japan?

Value in health, 2024-06, Vol.27 (6), p.S284-S284

2024

Volltextzugriff (PDF)

MT26 HTA Requirements for Medical Technologies in Canada

Value in health, 2024-06, Vol.27 (6), p.S286-S286

2024

Volltextzugriff (PDF)

PSU36 Evidence Based Medicine: A Case Study of its Application to Innovative Surgical Procedures in the UK

Value in health, 2012-11, Vol.15 (7), p.A408-A408

2012

Volltextzugriff (PDF)

Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial

American journal of clinical dermatology, 2003, Vol.4 (2), p.131-139

2003

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(69)

Sprache

Englisch
(68)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Internal Medicine
(25)
Humans
(12)
Science & Technology
(11)
Life Sciences & Biomedicine
(10)
Female
(7)
Male
(7)
Middle Aged
(7)
Quality Of Life
(6)
Surveys And Questionnaires
(6)
Business & Economics
(5)
Economics
(5)
Health Care Sciences & Services
(5)
Health Policy & Services
(5)
Social Sciences
(5)
United States
(5)
Adult
(4)
Aged
(4)
Self Report
(4)
Biological And Medical Sciences
(3)
Dermatologic Agents - Therapeutic Use
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

SAT0300 Treatment experience and satisfaction in ankylosing spondylitis patients treated with secukinumab: results from a us web-based survey

FDA PATIENT-REPORTED OUTCOME LABELING OF NOVEL THERAPIES (2011-2015)

United States decision maker perceptions of data from observational studies and other Health Economics and outcomes research

PNS226 A CONSOLIDATED FRAMEWORK FOR COLLABORATION IN RWE GENERATION FOR A MEDICAL PRODUCT

Evidence-Based Medicine, Appropriate-Use Criteria, and Sports Medicine: How Best to Develop Meaningful Treatment Guidelines

PCR74 Trends in the Inclusion of Patient Reported Outcomes in Oncology Clinical Trials: Analysis of ClinicalTrials.gov (2013-2022)

PRM111 Pediatric Patient-Reported Outcomes Assessment: A Case Study in Epidermolysis Bullosa

Payer Needs In Emerging Markets: How Should These Needs Be Included In Dermatology Drug Development Plans?

“Safe And Effective” Versus “Reasonable And Necessary”: Is The Deck Stacked Against Devices?

Psychometric Evaluation Of The Patient's Knee Implant Performance (PKIP) Questionnaire For The Assessment Of Primary Total Knee Arthroplasty

PHP182 Concordance of PRO Labeling Claims Between the FDA and EMA

Psychometric Evaluation Of The Psoriasis Symptom Diary Using Phase 3 Trial Data

MT61 Differences and Similarities of Health Economic Evaluation for Medical Technologies By HTA Bodies

MT25 What Evidence Should Medical Technology Companies Expect HTA Bodies to Review?

MT44 Submission Process and Requirements of Nordic Health Technology Assessment Organisations for Medical Technologies: Results of an Online Survey

MT13 Digging into the Medical Technology HTA Process in Tunisia

MT43 Does Real-World Evidence Play a Role in Decision-Making by HTA Bodies for Medical Technologies?

MT29 Understanding How Health Technology Assessment Bodies Select Medical Technology for Review: Results of an Online Survey

PIH49 Patient Reported Outcomes as Primary Endpoints in Confirmatory Clinical Trials

PIH53 Assessment of PRO Labels Claims Granted by the FDA as Compared to the EMA

Surgical Innovation: Do We Need A More Balanced Framework For Evidence?

MT16 What Is the Medical Technology HTA Process in Japan?

MT26 HTA Requirements for Medical Technologies in Canada

PSU36 Evidence Based Medicine: A Case Study of its Application to Innovative Surgical Procedures in the UK

Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial

Aktive Filter

Suchergebnisse filtern